5-Azacytidine Treatment Inhibits the Development of Lung Cancer Models via Epigenetic Reprogramming and Activation of Cellular Pathways With Anti-Tumor Activity. Med Pharm Rep 2024, 97 (4), 488-506. https://doi.org/10.15386/mpr-2777.